This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrinology
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:18628/feed
ISSN 2327-2236
Cardiovascular Conditions
Vol. 1, Issue 3, 2014February 25, 2014 EDT

Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database

Ariel Berger, John Edelsberg, Simon Teal, Marko A. Mychaskiw, Gerry Oster,
medication adherencepharmacotherapyrevatio®sildenafil citratepulmonary arterial hypertension
Copyright Logoccby-4.0
Photo by Nhia Moua on Unsplash

Articles in Vol. 1, Issue 3, 2014

Vol. 1, Issue 3, 2014
  • Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany
    Nikolaos KotsopoulosMark P. ConnollyEsther SobanskiMaarten J. Postma
  • Comparing Health Care Financing in Indonesia and Thailand from 1995-2010: What Lessons Could Be Learned?
    Darius ErlanggaLizheng Shi
  • Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
    Jona T. StahmeyerSvenja SchauerSiegbert RossolHans Heinrich WedemeyerDaniel WirthFlorence BianicChristian Krauth
  • Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
    Ariel BergerJohn EdelsbergSimon TealMarko A. MychaskiwGerry Oster
  • Health Care Costs attributable to Hospital-diagnosed Back Pain: A Longitudinal Register-based Study of the Danish Population
    Rikke SøgaardJan Sørensen
  • Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring
    Zuleika Saz-ParkinsonMaria Del Sol Granados AlonsoCarmen BouzaJosé Luis Poveda AndrésJosé María Amate
  • The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
    Zeynal KaracaSteven N. Wiggins
  • An Algorithm to Analyze Cost Heterogeneity using Counterfactual Scenarios in Endovascular versus Open Repair of Abdominal Aortic Aneurysm: Predicting Costs for Subsequent Patients
    Christopher A. JonesPeter W. CallasRobert W. EverettRichard A. GalbraithRichie SpitsbergJeffrey J. PetrozzinoMichael J. DeSarnoAndrew C. Stanley
JHEOR
1.
Berger A, Edelsberg J, Teal S, Mychaskiw MA, Oster G. Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database. JHEOR. 2014;1(3):254-265.
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system